Signaling pathways
-
BA5281 NBI-27914Summary: NBI-27914 is a potent and selective CRFR1 antagonist. - BA5282 TildacerfontSummary: Tildacerfont is a potent and orally active inhibitor.
- BA5283 PexacerfontSummary: Pexacerfont is a selective adrenocorticotropin-releasing factor receptor antagonist.
- BA5284 AntalarminSummary: Antalarmin is a selective nonpeptide adrenocorticotropic hormone releasing factor receptor 1 antagonist.
- BA5285 EmicerfontSummary: Emicerfont is a proadrenocorticotropic hormone releasing factor type 1 receptor antagonist.
- BA5286 LIT-927Summary: LIT-927 is a localized, orally active neutral ligand for CXC chemokine 12.
- BA5287 AZD8797Summary: AZD8797 is a noncompetitive, orally available human variant antagonist.
- BA5288 AZD-5069Summary: AZD-5069 is an effective antagonist.
- BA5289 SX-682Summary: SX-682 is an orally effective alteration inhibitor.
- BA5290 ACT-1004-1239Summary: ACT-1004-1239 is a potent, selective, oral antagonist.